CG
STJ

Cutler Group’s St Jude Medical STJ Stock Holding History

Cutler Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-204,500
Closed -$26K – 7884
2016
Q4 		$26K Sell
204,500
-54,600
-21% -$4.33M ﹤0.01% 3210
2016
Q3 		$212K Buy
259,100
+150,300
+138% +$12.1M 0.01% 1159
2016
Q2 		$93K Buy
108,800
+102,900
+1,744% +$7.34M ﹤0.01% 1749
2016
Q1 		$11K Buy
+5,900
New +$321K ﹤0.01% 3995

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Cutler Group's STJ Position: Q1 2017 in Review

Cutler Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 300 shares — an estimated $24K sold.

Cutler Group first reported a position in STJ in Q1 2016 and held it in 3 quarters. The position peaked at $2.11M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cutler Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cutler Group sold 300 St Jude Medical shares in Q1 2017, an estimated $24K.
  • Cutler Group first reported a position in St Jude Medical in Q1 2016 and held it in 3 quarters.
  • Cutler Group's St Jude Medical position peaked at $2.11M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.